Azelnidipine Ethyl imp is a dihydropyridine-based calcium channel blocker impurity, featuring an ethyl ester substitution at the 3-position of the pyridine ring, alongside a nitrophenyl group and a dimethylaminoethyl side chain. This compound arises as a synthetic byproduct during the esterification step of azelnidipine production, retaining the core 1,4-dihydropyridine scaffold but with an ethyl moiety replacing a methylene bridge. Its structural similarity to the parent drug enables competitive binding in analytical assays, serving as a critical HPLC reference standard for quantifying process-related impurities in azelnidipine APIs.
On RequestCCOC(=O)C1=C(C)NC(N)=C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1
InChI=1/C32H32N4O6/c1-3-41-31(37)26-20(2)34-30(33)28(27(26)23-15-10-16-24(17-23)36(39)40)32(38)42-25-18-35(19-25)29(21-11-6-4-7-12-21)22-13-8-5-9-14-22/h4-17,25,27,29,34H,3,18-19,33H2,1-2H3
FCEVTPOMNWRLQN-UHFFFAOYNA-N